Nonoperating Income (Expense) in USD of TNF Pharmaceuticals, Inc. from Q1 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to Q3 2025.
  • TNF Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$1.02M, a 886% decline year-over-year.
  • TNF Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $525K.
  • TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was -$13.2M, a 201% decline from 2023.
  • TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.1M, a 15262% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $85.4K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

TNF Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $525K -$1.02M -$919K -886% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-19
Q2 2025 $1.44M $76.4K +$6.27M Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-19
Q1 2025 -$4.83M $1.35M +$8.36M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$13.2M $125K -$2.42M -95.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-11
Q3 2024 -$10.8M -$104K -$7.99M -101% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-19
Q2 2024 -$2.78M -$6.2M -$7.81M -484% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-19
Q1 2024 $5.03M -$7.02M -$8.09M -750% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $13.1M $2.54M +$2.48M +3971% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-11
Q3 2023 $10.6M $7.89M +$7.87M +48721% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $2.77M $1.61M +$1.61M +23176% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $1.16M $1.08M +$1.08M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $85.4K $62.5K +$310K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$225K $16.2K +$1.08M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.3M $6.93K -$179K -96.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.12M -$180 -$41.9K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.08M -$248K -$267K -1394% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$812K -$1.06M -$1.06M -784602% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $247K $186K +$215K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $31.9K $41.7K +$31.7K +317% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-18
Q4 2020 $141 $19.2K -$93.1K -82.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $93.2K $135 -$28.3K -99.5% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-11-15
Q2 2020 $122K -$29.1K -$2.32K -8.65% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $124K $9.99K +$33K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-18
Q4 2019 $90.8K $112K -$796K -87.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $887K $28.5K +$68.8K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $818K -$26.8K +$18.9K +41.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $799K -$23K +$10.4K +31.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $789K $908K +$140K +18.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 $648K -$40.4K -$40.4K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $689K -$45.7K -$43.1K -1624% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $732K -$33.5K -$20.6K -160% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $753K $768K +$738K +2451% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $14.6K $68.00* -$8.83K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $23.5K -$2.65K +$3.22K +54.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $20.2K -$12.9K -$4.85K -60.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-07-13
Q4 2016 $25.1K $30.1K +$43.3K Oct 1, 2016 Dec 31, 2016 10-K/A 2018-07-13
Q3 2016 -$18.3K $8.89K +$27.4K Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-07-13
Q2 2016 -$45.7K -$5.87K +$24.9K +80.9% Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-07-13
Q1 2016 -$70.6K -$8.03K +$30.4K +79.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$101K -$13.2K +$42.5K +76.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-11
Q3 2015 -$143K -$18.5K -$72 -0.39% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$143K -$30.8K -$10.3K -50.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$133K -$38.4K -$56.2K -316% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$77K -$55.8K -$55K -7446% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$21.9K -$18.4K -$19.3K -2380% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$2.67K -$20.5K -$212K -111% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 $209K $17.8K -$74.5K -80.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $284K -$739 Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $809 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $192K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $92.3K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14

TNF Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$13.2M -$26.3M -201% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-11
2023 $13.1M +$13M +15262% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-11
2022 $85.4K +$1.16M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$1.08M -$1.08M -765588% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $141 -$90.7K -99.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $90.8K -$698K -88.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $789K +$36.1K +4.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $753K +$727K +2898% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $25.1K +$126K Jan 1, 2016 Dec 31, 2016 10-K/A 2018-07-13
2015 -$101K -$24K -31.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-11
2014 -$77K -$361K -127% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $284K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.